GISONDI, P.; LOCONSOLE, F.; RAIMONDO, P.; RAVASIO, R. Cost per responder for risankizumab vs secukinumab in patients with moderate-to-severe plaque psoriasis in Italy. Global and Regional Health Technology Assessment, [S. l.], v. 8, n. 1, p. 120–130, 2021. DOI: 10.33393/grhta.2021.2258. Disponível em: https://journals.aboutscience.eu/index.php/grhta/article/view/2258. Acesso em: 29 mar. 2024.